Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Y
Yang, Tianzhi
Western New England University
(
T1030-01-02
)
Blueberry-Derived Exosomes as a Natural miRNA Delivery System for the Treatment of Neurodegenerative Diseases
Tianzhi Yang
Favorite
Yannoni, Yvonne
Cullinan Therapeutics
(
M1230-02-07
)
Development and Validation of a High-Sensitivity PK Assay for CLN-978 Supporting a First in Human Study in Systemic Lupus Erythematosus Using Quanterix SIMOA Technology
Yvonne Yannoni
Favorite
Yarraguntla, Srinivasa Rao
Vignan University
(
T1230-01-01
)
Mutagenic NDSRI of Citalopram - Critical Structural Evaluation of Carcinogenic Category and Development of a Highly Sensitive LC-MS/MS Method Development for Quantification
Srinivasa Rao Yarraguntla
Favorite
Ybarra, Elijah
Eurofins VIracor BioPharma Services
(
M1230-02-08
)
Comprehensive AAV-Based Vector Shedding Assessment by PCR: A Case Study with Whole Blood, Serum, Semen, Urine, and Buccal Swab
Elijah Ybarra
Favorite
Ye, Nan
Boehringer Ingelheim
(
T1030-02-08
)
Systematic Optimization of ADA Assays for Complex Biologics: A Framework for Addressing Assay Challenges Across Modalities
Nan Ye
Favorite
Ye, Sally
Boehringer Ingelheim
(
T1030-02-08
)
Systematic Optimization of ADA Assays for Complex Biologics: A Framework for Addressing Assay Challenges Across Modalities
Sally Ye
Favorite
Ye, Stan
Novartis
(
T1230-02-08
)
Reverse Translational Modeling for Early Benchmarking of Clinically Active Doses from In Vitro Cell Killing and T-Cell Activation Data for BCMAxCD3 T-Cell Engagers
Stan Ye
Favorite
Ying, Xi
Georgia Institute of Technology
(
T1330-01-02
)
Optimizing Gel Network Architecture for Oxanorbornadiene-Based Degradable Hydrogels
Xi Ying
Favorite
Younes, Husam
Qatar University
(
M1430-01-02
)
Revolutionizing Ocular Drug Delivery: Prolonged Sunitinib Release from Elastomeric Biodegradable Injectable Tiny Implants for Treatment of Diabetic Retinopathy
Husam Younes
Favorite
You, Zhiping
Pfizer Inc.
(
M1130-02-07
)
Embracing Singlicate Ligand Binding Biomarker Assays: A Case Study Comparing Duplicate vs Singlicate Analysis for the Determination of IL-6, IFN-gamma, and TNF-alpha in Human Sodium Heparin Plasma
Zhiping You
Favorite
Yu, Mathilde
Cerba Research
(
T1130-02-07
)
Mitigation of the Presence of Crosstalk in an ADA Bridging Assay Using the MSD Platform for the Detection of Antibodies against an Antibody-Drug Conjugate
Mathilde Yu
Favorite
Yun, Sang Hyeon
TriOar Inc.
(
M1230-02-06
)
Application of icIEF-UV/MS for Rapid Proteoform Characterization and Charge Variant Analysis of a Novel Antibody-Drug Conjugate in Drug Discovery
Sang Hyeon Yun
Favorite
(
M1530-02-08
)
Charge Variant Profiling of Antibody-Drug Conjugate Containing Auristatins Using icIEF-UV-MS
Sang Hyeon Yun
Favorite
Yu, Yanjiao
Tavotek Biotherapeutics
(
T1330-02-09
)
Preliminary Phase 1a Clinical Results of Multispecific Antibody TAVO412 in Patients with Hard-to-Treat Solid Tumors
Yanjiao Yu
Favorite
Yu, Zhihao
Institut des Matériaux Poreux de Paris
(
M0930-01-02
)
Exploring the Impact of Iron Availability on Morphology and Antibiotic Resistance in
Mycobacterium
Species
Zhihao Yu
Favorite
